Is the dietary supplement industry getting a handle on the adulteration issue? The baseline data does not exist to be able to say one way or another. But sources agree that in the one thing you can measure—the attention the issue is getting—the situation is improving.
Attempts to reach a federal GMO labeling solution have failed miserably to date. However, a bipartisan deal requiring mandatory GMO labeling (via smartlabels, symbols or as yet undetermined wording) thrashed out in the Senate on Thursday looks like it could prove the exception to the rule.
A combination of more prevalent digestive issues and effects consumers can feel are boosting the US probiotics sector, says the CEO of NutraClick.
The developers of a new hangover supplement believe careful pre launch market analysis will help them succeed where others have failed.
For the first time the European Union has lost a member after the British people yesterday voted to leave the bloc which began life as the European Economic Community in 1951.
Cardiac surgery patients given omega-3 polyunsaturated fatty acids (PUFAs) beforehand found their hospital stay reduced by up to 2.4 days, an analysis has suggested.
Randomized, placebo-controlled trials are a straitjacket for nutritional science, making FTC’s hardening stance an increasing burden on industry, experts said at the recent CRN conference. The approach poses ethical quandaries and may even have statistical traps built in, they said.
Content Provided by Kyowa Hakko
Heart disease is a rare case of a big problem with a clear solution: Lower LDL. In Pantesin, manufacturers have an ingredient with a 40-year history of doing just that.